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Aim of the study was to evaluate the role ot
postoperative external irradiation in the
treatment of patients with high risk of local
relapse of soft tissue sarcomas, as well as to
evaluate the long-term results of this combined
treatment. Data charts of the 77 patients with
STS treated by surgery and postoperative
external beam radiotherapyin Institute of
Oncology in Gliwice during the period 1990-
1999 has been reviewed. Extremity was the
most frequent tumour site (75%), folIowed by
trunk (10%), pelvis (7%), head and ileck (4%)
and retroperitoneal space (4%). Histological
types included liposarcoma (27%), MFH (23%),
fibrosarcoma (22%), neurosarcoma (12%),
synovial sarcoma (8%) and others (8%). Only in
52% of patients the grade of the tumour was
evaluated (G1-12 pts, G2-14 pts, G3·14 pts).
Only 23 patients (30%) was treated by
chemotherapy after local treatment. In majority
patients were primary operated at general
surgery departments, outside the reference
centre with technique typical for benign tumours.
Because of non-radical first surgical treatment
and large number of early local recurrences in a
whole group over 140 operations has been
undertaken. Surgical margins were proven by
histological procedures only in 29% of the
patients. Long term OS, DFS and LC rates
have been 64%, 56% and 69% respectively.
Distant metastases have occurred in 30% of pts.
during the first 2 years of observation.
Prognostic factors have been evaluated in both
univariate and multivariate analysis. The most
important positive prognostic factors were as
follows: radical surgical treatment and
concomitant chemo-radiotherapy.
The first, often proven or suspected as non-
radical, tumour excision is the most important
and probably independent negative prognostic
factor for tumour cure and patient survival. For
such clinical situations secondary surgical
approach as a wide excision is recommended.
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Because of a large number of cases in analysed
material with single ar multiple local relapses
decision of adjuvant therapy has to be
considered individually. It seems that in such
clinical situation, postoperative radiotherapy or
aggressive radio-chemotherapy in cases with no
clinically detected local relapse gives the best
chance for survival. The long time ot anamnesis,
several surgical treatments of tumour relapses
with no sarcoma policy stress the need to
establish the general national rules for diagnosis
and adjuvant treatment of soft tissue sarcomas.
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A quality assurance system in stereotactic
radiosurgery and stereotactic fractionated
radiotherapy, concerning the physical and
dosimetric aspects, may be divided into three
elements: (1) the preparation of reliable basic
data for the computerized treatment planning
system; (2) acantroi of the accelerator
parameters prior to patient treatment; (3)
preparation ot the optimal treatment plan with
the treatment planning system.
Due to the smali size ot the beams tormed by
circular collimators (7.5-35mm diameter,
BrainLab System) the smallest available
detectors should be used tor measurements -
a diamond diode (0.3 mm thickness) and a
0.015 cm3 ionization chamber (PTW Freiburg)
are adequate to measure precisely TMR curves,
beam profiles and output factors required for the
treatment planning system BrainScan.
The fuli control of accelerator parameters
(Clinac 2300 C/D) necessary to safely carry out
the treatment requires a comprehensive list ot
tests (an extended list of weekly checks
including Winston-Lutz test). Testing procedure
carried out with a set ot specialized devices
(Med-Tec, Radak, BrainLab) takes about twa
hours. Proper accelerator check and
regulations allow tor very precise patient
positioning.
Treatment planning (with the treatment
planning system BrainScan) is based on a
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